Sort
82,697 grants matching “vaccine development”
Antibody immunotherapeutics for biodefense against Lassa virus
$1,238,702Robert F Garry · Tulane University Of Louisiana · R01 · FY2016 · AI
Medical Scientist Training Program
$1,238,676Christopher S. Williams · Vanderbilt University · T32 · FY2017 · GM
Studies on Arthropod Vectors of Disease
$1,238,602Robert Gwadz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$1,238,541Deborah L. Fuller · Albany Medical College · U01 · FY2009 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2012 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2016 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning
$1,238,429Konstantin Ichtchenko · New York University School Of Medicine · R01 · FY2015 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,238,374Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,238,320Eric Hunter · Emory University · R01 · FY2008 · AI
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
$1,238,182Jane C Burns · University Of California, San Diego · R33 · FY2023 · HD
Monoclonal Antibodies in Biodefense: Ebola Viruses
$1,238,148Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2007 · AI
Laboratory Support
$1,238,055Wendy Stevens · Wits Health Consortium (Pty), Ltd · U19 · FY2007 · AI
CD40L-Adjuvanted Vaccines for HIV/AIDS
$1,237,954Rama Rao Amara · Emory University · P01 · FY2011 · AI
Novel Strategies for Brain Tumor Therapy
$1,237,376Ian F. Pollack · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · NS
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$1,236,847Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Colorado AIDS Clinical Trials Unit
$1,236,675Thomas B. Campbell · University Of Colorado Denver · U01 · FY2007 · AI
DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES
$1,236,651Emily Voigt · Access To Advanced Health Institute · N01 · FY2023 · AI
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,236,590Mark Larche · Mcmaster University · U19 · FY2016 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages
$1,236,573Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$1,236,519Johns Hopkins University · U19 · FY2002 · CA
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
$1,236,361Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2007 · AI
San Antonio STI TM CRC
$1,236,129University Of Texas Hlth Sci Ctr San Ant · U19 · FY2004 · AI
Surgery Branch Cell Prep Core
$1,236,025John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Cell Production Core Facility
$1,236,025Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,235,927Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2018 · AI